Institutional Repository of Vilnius University
4-(1-aril-1H-imidazol-5-il)-6-cikloalkilbenzen-1,3-diolių ir 6-(5-aril-1,2,3-tiadiazol-4-il)-4-cikloalkilbenzen-1,3-diolių sintezė šaperono Hsp90 slopiklių paieškai /
Abstract
dc:descriptionThe development of drugs to treat diseases related to the Hsp90 protein's principle of action is currently a major focus. The structure of the compounds included in such drugs often contains heterocyclic systems of imidazoles or thiadiazoles. 1,3-benzenediol was used as a starting material, for the synthesis of aldehydes and hydrazinecarboxylates which were used to synthesize 4-(1-aryl-1H-imidazol-5-yl)-6-cycloalkylbenzene-1,3-diols and 6-(5-aryl-1,2,3-thiadiazol-4-yl)-4-cycloalkylbenzene-1,3-diols, respectively. After the analysis of different methods for the synthesis of thiadiazole and imidazole heterocyclic systems, the van Leusen-imidazoles and Hurd-Mori-thiadiazoles synthesis methods were chosen. The synthesis proceeded smoothly and seven potential Hsp90 protein inhibitors were successfully obtained, five of which were 4-(1-aryl-1H-imidazol-5-yl)-6-cycloalkylbenzene-1,3-diols and two of which were 6-(5-aryl-1,2,3-thiadiazol-4-yl)-4-cycloalkylbenzene-1,3-diols. Two additional new compounds, as side products of the van Leusen reaction, were also isolated: 1-(4-chlorophenyl)-7-(cyclobuthyllmethyl)-3a-8b-dihydro-1H-benzofuro[2,3-d]imidazol-6-ol and 1-(4-chlorophenyl)-7-(cyclopropylmethyl)-3a-8b-dihydro-1H-benzofuro[2,3-d]imidazol-6-ol.
Degree
thesis:*- Grantor dc:publisher
- Institutional Repository of Vilnius University
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Venskūnaitė, Kamilė,
Rights
dc:rights- Statement dc:rights
-
- info:eu-repo/semantics/openAccess
- Language dc:language
- lit
Identifiers
dc:identifier.*- Repository record dc:identifier
- https://repository.vu.lt/VU:ELABAETD192844611&prefLang=en_US